These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 20121682)

  • 1. Current concepts in the management of Parkinson disease.
    Hayes MW; Fung VS; Kimber TE; O'Sullivan JD
    Med J Aust; 2010 Feb; 192(3):144-9. PubMed ID: 20121682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of motor and non-motor symptoms in Parkinson's disease.
    Sprenger F; Poewe W
    CNS Drugs; 2013 Apr; 27(4):259-72. PubMed ID: 23515972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and Treatment of Parkinson Disease: A Review.
    Armstrong MJ; Okun MS
    JAMA; 2020 Feb; 323(6):548-560. PubMed ID: 32044947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beating a dead horse: dopamine and Parkinson disease.
    Ahlskog JE
    Neurology; 2007 Oct; 69(17):1701-11. PubMed ID: 17954785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current and experimental treatments of Parkinson disease: A guide for neuroscientists.
    Oertel W; Schulz JB
    J Neurochem; 2016 Oct; 139 Suppl 1():325-337. PubMed ID: 27577098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment.
    Chaudhuri KR; Schapira AH
    Lancet Neurol; 2009 May; 8(5):464-74. PubMed ID: 19375664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatments for Parkinson disease--past achievements and current clinical needs.
    Poewe W
    Neurology; 2009 Feb; 72(7 Suppl):S65-73. PubMed ID: 19221317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathophysiological process underlying Parkinson's disease: motor & non-motor symptoms].
    Takeda A; Baba T; Kikuchi A; Sugeno N; Hasegawa T; Itoyama Y; Ishioka T; Hirayama K; Mori E
    Rinsho Shinkeigaku; 2009 Nov; 49(11):888-9. PubMed ID: 20030239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Updates and advances in the treatment of Parkinson disease.
    Hayes MW; Fung VS; Kimber TE; O'Sullivan JD
    Med J Aust; 2019 Sep; 211(6):277-283. PubMed ID: 31203580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Approach to the patient with Parkinson disease.
    Johnson KE
    Prim Care; 2015 Jun; 42(2):205-15. PubMed ID: 25979582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Initial management and adaptation of Parkinson's disease treatment].
    Gérard JM
    Rev Med Brux; 2008 Sep; 29(4):229-31. PubMed ID: 18949969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and neuropsychological follow up at 12 months in patients with complicated Parkinson's disease treated with subcutaneous apomorphine infusion or deep brain stimulation of the subthalamic nucleus.
    De Gaspari D; Siri C; Landi A; Cilia R; Bonetti A; Natuzzi F; Morgante L; Mariani CB; Sganzerla E; Pezzoli G; Antonini A
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):450-3. PubMed ID: 16543520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinson's Disease.
    Reich SG; Savitt JM
    Med Clin North Am; 2019 Mar; 103(2):337-350. PubMed ID: 30704685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levodopa unresponsive symptoms in Parkinson disease.
    Sethi K
    Mov Disord; 2008; 23 Suppl 3():S521-33. PubMed ID: 18781679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease.
    Dafsari HS; Martinez-Martin P; Rizos A; Trost M; Dos Santos Ghilardi MG; Reddy P; Sauerbier A; Petry-Schmelzer JN; Kramberger M; Borgemeester RWK; Barbe MT; Ashkan K; Silverdale M; Evans J; Odin P; Fonoff ET; Fink GR; Henriksen T; Ebersbach G; Pirtošek Z; Visser-Vandewalle V; Antonini A; Timmermann L; Ray Chaudhuri K;
    Mov Disord; 2019 Mar; 34(3):353-365. PubMed ID: 30719763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic Effect on Non-Motor Symptoms in Late Stage Parkinson's Disease.
    Rosqvist K; Odin P; Hagell P; Iwarsson S; Nilsson MH; Storch A
    J Parkinsons Dis; 2018; 8(3):409-420. PubMed ID: 30056433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensory abnormalities and pain in Parkinson disease and its modulation by treatment of motor symptoms.
    Cury RG; Galhardoni R; Fonoff ET; Perez Lloret S; Dos Santos Ghilardi MG; Barbosa ER; Teixeira MJ; Ciampi de Andrade D
    Eur J Pain; 2016 Feb; 20(2):151-65. PubMed ID: 26147660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Apomorphine in advanced Parkinson disease].
    Bogucki A
    Neurol Neurochir Pol; 2013; 47(5):476-83. PubMed ID: 24166569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 200-year journey of Parkinson disease: Reflecting on the past and looking towards the future.
    Fahn S
    Parkinsonism Relat Disord; 2018 Jan; 46 Suppl 1():S1-S5. PubMed ID: 28784297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.